Smith & Nephew plc ADR (SNN) at a glance

Smith & Nephew plc ADR (SNN) is a large-cap Healthcare company. It trades at $27.5, with a P/E of 21.4, a 10.1% profit margin and revenue growth of 7.4%. It pays a 2.6% dividend yield. Vestovix scores it 61/100 overall. Its strongest dimension is Growth (80/100) and its weakest is Momentum (4/100). It is a relatively defensive holding with below-market volatility.

Price
$27.50
Market cap
$12.97B
P/E ratio
21.4
Dividend yield
2.57%
Beta
0.67
52-week range
$28.56 to $38.79
Vestovix Score61/ 100How this works
Value
62
Growth
80
Income
54
Safety
70
Momentum
4

Other Healthcare stocks

See all